MedPath

Combined Effects of Alcohol and Caffeine

Phase 1
Completed
Conditions
Alcohol or Other Drugs Effects
Interventions
Registration Number
NCT01289561
Lead Sponsor
Johns Hopkins University
Brief Summary

The purpose of this study is to investigate the effects of caffeine on the self-administration of alcohol. The study will also examine the combined effects of alcohol and caffeine on behavioral performance, participant ratings of behavioral performance, and self-reported subjective effects.

Detailed Description

The purpose of this study is to examine the effects of caffeine on alcohol self-administration. Volunteers will participate in 7 experimental sessions in which they will be given the opportunity to self-administer an alcohol + caffeine or alcohol + caffeine-placebo beverage. The first 6 sessions will involve exposure to the two beverage conditions in mixed order three times each (e.g., A, B, B, A, A, B). The seventh session will be a choice session in which the participant will make a single choice at the beginning of the session about which beverage they will consume that day. In addition to the primary outcomes of quantity of alcohol self-administered and beverage choice, three additional outcomes will be measured including: 1). indirect measures of reinforcing effects (e.g. subjective ratings of liking, well-being, take again); 2). an alcohol-sensitive behavioral measure; and 3). participant ratings of degree of behavioral impairment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Very light or moderate consumer of caffeine (either daily or non-daily).
  • Social drinker of alcohol.
  • Has experience in lifetime of heavy alcohol consumption.
  • Read, write, and speak English fluently.
Exclusion Criteria
  • Serious and unstable illnesses including current hepatic, renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease, uncontrolled hypertension, and congestive heart failure), endocrinologic, neurologic (including stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor, encephalopathy, and meningitis), or hematologic disease.
  • Parkinson's disease, seizure disorder, or history of significant head trauma.
  • Current psychiatric illness
  • Pregnant or nursing women or women who are not using an effective means of birth control.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Alcohol self-administrationAlcohol + Caffeine-placeboAll participants will participate in seven sessions. In three sessions, each participant will consume a beverage containing alcohol and caffeine. In three separate sessions, participants will consume a beverage containing alcohol and caffeine-placebo. In the final session, all participants may choose which beverage they consume. Participants and research assistants will be blinded to inclusion of caffeine/caffeine-placebo in beverage, but each beverage will be labeled for identification (e.g., A or B).
Alcohol self-administrationAlcohol + Caffeine BeverageAll participants will participate in seven sessions. In three sessions, each participant will consume a beverage containing alcohol and caffeine. In three separate sessions, participants will consume a beverage containing alcohol and caffeine-placebo. In the final session, all participants may choose which beverage they consume. Participants and research assistants will be blinded to inclusion of caffeine/caffeine-placebo in beverage, but each beverage will be labeled for identification (e.g., A or B).
Primary Outcome Measures
NameTimeMethod
Total beverage consumedMeasured during 2.5 hour drinking period

The primary outcome measure is the total volume of beverage consumed during alcohol + caffeine sessions and alcohol + caffeine-placebo sessions.

Secondary Outcome Measures
NameTimeMethod
Circular Lights TaskApproximately every 30 minutes of the 5.5 hour study period

The Circular Lights Task is a measure of behavioral performance

The Biphasic Alcohol Effects ScaleApproximately every 30 minutes of the 5.5 hour study period

The Biphasic Alcohol Effects Scale (BAES: Martin et al., 1993) will be repeatedly administered to assess changes in subjective alcohol effects over time. This measure is a commonly used 14-item scale that assesses stimulant (7 items) and sedative (7 items) subjective effects of drugs on a 10-point likert scale

Subjective ratings 9-point likert scaleApproximately every 30 minutes during the 5.5 hour study period

The following three questions will be asked on a 9-point likert scale:

1. How much do you like the beverage you have been drinking today?

2. Rate your sense of "well-being" right now.

3. How much money would you be willing to pay for a standard mixed drink serving (e.g., 8 oz.) of this beverage at a bar?

Expired air breath alcohol measuresApproximately every 30 minutes during the 5.5 hour study period

Breath alcohol measures will be taken repeatedly in order to assess blood alcohol levels, as well as assure safe discharge. In order to prevent mouth alcohol contamination of breath alcohol measurements, participants will be required to abstain from drinking for 5 minutes before each measurement and to rinse their mouth out thoroughly with water immediately before breath alcohol measures.

Subjective ratings visual analogue scaleApproximately every 30 minutes during the 5.5 hour study period

The following two questions will be answered on a visual analogue scale:

1. How much do you want another drinking right now?

2. How intoxicated do you feel?

Trial Locations

Locations (1)

Behavioral Pharmacology Research Unit

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath